HHLR Advisors, LTD.
HHLR Advisors, LTD. is an exempt reporting adviser based in Singapore, Singapore that reports managing 2 hedge funds on Form ADV. Its private funds, of all types, hold $22.1 billion in gross assets. Its disclosed U.S. stock holdings returned an estimated -16.7% 2026 YTD through Jun 30 (S&P 500: +9.5%), based on 13F filings. Over a longer period they returned an estimated +10.4% from Q3 2024 to Q2 2026, compared with +37.2% for the S&P 500, based on 13F filings.
- Regulatory assets under management
- —Form ADV Item 5.F
- Gross assets of private funds
- $22.1 billionAll private fund types, Form ADV
- Hedge funds managed
- 22 private funds in total
- Employees
- —Form ADV Item 5.A
- Registration
- Exempt reporting adviserCRD 166112
- Latest Form ADV
- 03/31/2026Disciplinary disclosures: none reported
Estimated 13F portfolio performance
| Quarter | Est. 13F return | S&P 500 |
|---|---|---|
| Q2 2026 | -5.9% | +14.8% |
| Q1 2026 | -11.5% | -4.6% |
| Q4 2025 | -16.4% | +2.4% |
| Q3 2025 | +23.8% | +7.8% |
| Q2 2025 | -0.9% | +10.4% |
| Q1 2025 | +25.3% | -4.5% |
| Q4 2024 | -16.6% | +2.1% |
| Q3 2024 | +23.6% | +5.4% |
Estimate of the firm's disclosed long U.S. stock portfolio from its quarterly 13F filings, holding each quarter-end portfolio to the next quarter-end at prices implied by all 13F filers. It is a price return before dividends and fees, ignores shorts, options, bonds, cash and trading within the quarter, and is not the return of any fund. Disclosures
Largest disclosed holdings
- Legend Biotech Corp$172.8 million
- Futu Hldgs LTD$165.8 million
- Arrivent Biopharma Inc$136.5 million
- Marvell Technology Inc Com$48.5 million
- Vipshop Hldgs LTD$46.0 million
- PDD Holdings Inc$38.1 million
- Ke Hldgs Inc$32.2 million
- Cytek Biosciences Inc$29.5 million
- 010911105$25.9 million
- Alibaba Group Holding Limited$17.7 million
As of 2026-06-30, from 13F filing by HHLR Advisors, LTD..
From SEC filings. Firm data comes from the SEC's Form ADV data as of Oct 2, 2026; performance estimates come from Form 13F. HedgeMountain has not verified this information, and it is not an offer, solicitation or recommendation. Full disclosures